National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 26         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer

   
Phase IV

   
Dathyrca 1
EudrCT 2007-002713-39, HB-2007-043, Data register 2007-41-120, NCT00604318

 
 
Second-Line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

   
Phase III, Phase II

   
N07MAN
Eudract 2007-007030-20, NCT00684216

 
 
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

   
Phase III

   
NCRI-FOCUS2
MRC-CR09, EU-20303, NCT00070213

 
 
Laparoscopic Approach to Cancer of the Endometrium

   
Phase III

   
LACE001
NCT00096408

 
 
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

   
Phase III

   
TROG 03.01
NCIC CTG ES.2, TGA 2004/83, NHMRC 291103, NCT00193882

 
 
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

   
Phase III

   
FCCC-FCRB-04-002-P
NCT00372840

 
 
Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck

   
Phase III

   
186-03
ETH136-03D, NCT00206752

 
 
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

   
Phase III

   
2003-0925
NCT00418691

 
 
Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy

   
Phase III

   
kf 0102006-5491
NCT00435474

 
 
Radiation Doses and Fractionation Schedules in Non-Low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

   
Phase III

   
TROG 07.01
NHMRC 454390, NCT00470236

 
      1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov